Skip to main content

Animations

MJFF Publications

6941 - 6950 of 8816 Results
Title
Year
  • Year
  • 2016
  • 2025
  • 2023
  • 2019
  • 2012
  • 2024
  • 2019
  • 2025
  • 2014
  • 2020
  • Summary Details
    OPEN
    Title: N-acetylaspartate supports the energetic demands of developmental myelination via oligodendroglial aspartoacylase
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2016.10.001
    Citation Count: 39
  • Summary Details
    OPEN
    Title: Proteolytic activities of extracellular vesicles attenuate A-synuclein aggregation
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-01122-9
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Valbenazine as treatment for Huntington's disease chorea
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00163-1
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Increased Dynamics of α-Synuclein Fibrils by β-Synuclein Leads to Reduced Seeding and Cytotoxicity
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-019-54063-8
    Citation Count: 25
  • Summary Details
    RESTRICTED
    Title: The meaning of a “hippo” response on the Montreal Cognitive Assessment in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2012.09.005
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Determination of optimal vibration dose to treat Parkinson's disease gait symptoms: A clinical trial
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2024.100248
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo
    Journal Name: Journal of Visualized Experiments
    Publisher: MyJove Corporation
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3791/59758
    Citation Count: 43
  • Summary Details
    OPEN
    Title: Sex differences in the diagnosis latency of Parkinson's disease in Latin America
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107344
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Effects of long-term treatment with rotigotine transdermal system on dyskinesia in patients with early-stage Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.09.016
    Citation Count: 25
  • Summary Details
    RESTRICTED
    Title: Characterization of a Parkinson’s disease rat model using an upgraded paraquat exposure paradigm
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1111/ejn.14683
    Citation Count: 27
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.